JPRN-UMIN000000789已完成未知
Antiremodeling effect of leukotriene receptor antagonist (pranlukast) in asthmatic subjects with chronic airflow limitation as assessed with computed tomography (CT). - Antiremodeling effect of leukotriene receptor antagonist in asthmatic subjects.
Kyoto University Hospitaly0 个研究点目标入组 30 人开始时间: 2007年8月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects who suffered from respiratory tract infection in the previous month. Subjects who were taking NSAIDs.
研究者
相似试验
招募中
4 期
Prospective study effect of leukotriene receptor antagonist add on therapy in asthma : pilot studyShort acting inhaled bronchodilator will be permitted through out the trial.lung functionexacerbationAsthmaTCTR20200408006Faculty of medicine CM40
尚未招募
2 期
Does Leukotriene receptor antagonists improve outcomes of patients with allergic fungal rhinosinusitis.CTRI/2024/02/062794Christian Medical College Vellore
已完成
4 期
Clinical effect of luekotriene receptor antagonist on provocation symptom induced by Japanese cedar pollene antigen disc and grope for clinical marker of nasal obstractioJapanese cedar pollinosisJPRN-UMIN000001362Faculity of Medicine, University of Fukui60
已完成
不适用
A comparison study of leukotriene receptor antagonist plus topical nasal steroid versus oral antihistamine + topical nasal steroid versus leukotriene receptor antagonist + oral antihistamine + topical nasal in the treatment of perennial allergic rhinitisRespiratory: Allergic rhinitisRespiratoryPerennial allergic rhinitisISRCTN02329306Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)60
进行中（未招募）
不适用
Effet d'un antagoniste du récepteur de l'endothéline 1 (Sitaxentan, Thelin) sur le remodelage bronchique au cours de l'asthme sévère avec obstruction bronchique persistante. - Entholéine et remodelage bronchique dans l'asthme sévèreasthme persistant modéré à sévèreMedDRA version: 9.1Level: LLTClassification code 10003554Term: Asthma aggravatedEUCTR2007-007481-38-FRINSERM